# Nicotine Polacrilex Lozenge Mint

NDC: 63868-733
Generic name: Nicotine Polacrilex Lozenge 2 mg
Labeler / Manufacturer: Chain Drug Marketing Association INC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: LOZENGE
Routes: ORAL
Marketing started: 20210401

FDA application: ANDA212796

## Active ingredients

- NICOTINE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63868-733"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63868-733
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0234492-d92d-ee93-493f-1099d4544722